M. Elizabeth Magill, the former dean of Stanford Law School, provost of the University of Virginia and president of the University of Pennsylvania, has been named the executive vice president and dean of Georgetown Law.
Georgetown Law’s deep and broad bench of environmental law experts gathered earlier this month to discuss former President Trump’s environmental track record and the Biden’s administration’s new direction.
Georgetown Law symposium to explore emerging and continuing threats with China facing the Biden Administration, Tues.- Weds., March 23-24
Updated March 21, 2021 Dear Georgetown Law Community, Like many of you, I spent most of spring break reflecting on recent events and thinking deeply about how we move forward together. The comments about Black students, made in a conversation between…
On the sidelines and during halftime performances, cheerleading for the Baltimore Ravens was the pinnacle of Amanda Ross’s career in cheerleading.
One year ago, police officers broke into a Kentucky apartment in the middle of the night and, after a single shot was fired in self defense, unleashed a fusillade of bullets.
Learn your craft, build your network, be passionate about what you do -- and never stop learning.
Each year, women and men alike gather in Washington, DC, to hear from inspiring Georgetown alumnae and professors on a variety of subjects. But this year was different.
WASHINGTON, BRUSSELS, GENEVA and SINGAPORE -- On Wednesday, March 10, 2021, Georgetown Law’s IIEL will host leading legal and policy experts from the U.S., EU, and China to discuss opportunities for transatlantic cooperation on WTO reform, as well as China’s role and perspective.
WASHINGTON – On Tuesday, March 9, 2021, Georgetown Law's Human Rights Institute will host a conversation on what's next for human rights in the Biden Administration. WHAT A military coup in Myanmar. Genocide against the Uyghurs in China. Humanitarian…
WASHINGTON & NEW DELHI – On Friday, March 5, 2021, legal experts from the U.S. and India consider how divergent approaches to patents implicate access to the Covid-19 vaccine.